A TALS-like associated RTTN mutation impedes neural rosette formation in human cortical organoids
Justine GuguiniD, Ting-Yu Chen, Alicia BessoniD, Silvestre CuinatiD, Eloïse BertiauxiD, Lucile BoutaudiD, Nolan Ardito, Miren Imaz Murguiondo, Sara CabetiD, Virginie HameliD, Sophie ThomasiD, Bertrand PainiD, Patrick EderyiD, Audrey PutouxiD, Tang K. TangiD, Sylvie MazoyeriD, Marion DelousiD
Abstract
The Taybi-Linder syndrome (TALS) is a rare genetic disorder characterized by a severe microcephaly with abnormal gyral pattern, severe growth retardation, bone abnormalities and a reduced life span for the most severe cases. It is caused by mutations in RNU4ATAC whose transcript, the small nuclear RNA U4atac, is a core component of the minor spliceosome involved in the excision of minor introns spread over [~]750 genes. Here, we report a patient presenting with TALS features but no mutation in RNU4ATAC; instead, she carries the RTTN c.2953A>G variant at the homozygous state. This variant, already reported in patients with syndromic microcephaly, encodes the missense p.Arg985Gly amino acid change. It is also known to affect RTTN pre-mRNA splicing, with the expression of two forms lacking either exon 23 (in-frame) or exons 22-23 (out-of-frame). By using the engineered RTTN depleted RPE1 cellular model, we analysed independently the impact of the missense and in-frame deletion of exon 23 RTTN isoforms on the localisation and function of the protein at the centrosome, and showed that the pathogenicity of the c.2953A>G variant is mostly due to the latter. In patient fibroblasts, we observed a reduction of the centriole length and an alteration of ciliary function, while the analysis of neuronal stem cells (NSC) derived from CRISPR/Cas9-edited induced pluripotent stem cells revealed major cell cycle and mitotic abnormalities, leading to aneuploidy, cell cycle arrest and increased cell death. Finally, by generating cortical organoids, we discovered a new function of RTTN in the self-organisation of NSC into neural rosettes. We observed a delayed apico-basal polarization of NSC, accompanied with decreased cell division and increased apoptosis. Altogether, these defects lead to a marked decrease of rosette number and size in RTTN-mutated organoids, thus impeding their overall growth. To conclude, our study gives new insights on microcephaly-related pathophysiological mechanisms underlying the only recurrent RTTN mutation, that could also open a path to better understand those involved in RNU4ATAC-associated Taybi-Linder syndrome.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 4
- FWCI
- 0.65
- Field percentile
- top 39%
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Deficiency of U4atac snRNA secondarily results in ciliary defects
Deepak Khatri, Audrey Putoux, … Marion Delous·Proceedings of the National Academy of SciencesPeer-reviewed·Feb 21, 2023
- RTTN moonlights beyond the centrosome to control ribosome biogenesis and tRNA modification in human brain organoids
Adva Hadar, Kalina Draganova, … Orly Reiner·bioRxiv·Aug 21, 2026
- TUBA1A mutations identified in lissencephaly patients dominantly disrupt neuronal migration and impair dynein activity
Jayne Aiken, Jeffrey K. Moore, Emily Anne Bates·Human Molecular GeneticsPeer-reviewed·Nov 29, 2018
- Modeling disease-correlated TUBA1A mutation in budding yeast reveals a molecular basis for tubulin dysfunction
E. Denarier, K. H. Ecklund, … C. Boscheron·bioRxiv·Apr 13, 2020
- MOPD I patient-derived cerebral organoids model microcephaly showing premature neurogenesis due to disrupted mitotic spindle orientation.
Jagjit Singh, Noah J. Daniels, … Richard A. Padgett·bioRxiv·Dec 29, 2022
- A de novo missense mutation in TUBA1A results in reduced neural progenitor survival and differentiation
Ashley M. Driver, Amy L. Pitstick, … Rolf W. Stottmann·bioRxiv·Oct 16, 2017